Bumrungrad Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	25,215	25,718	25,376	20,721	12,460
Other Revenue	233.86	144.87	170.76	186.97	144.1
Revenue	25,449	25,862	25,547	20,908	12,605
Revenue Growth (YoY)	-1.60%	1.23%	22.19%	65.87%	1.32%
Cost of Revenue	12,151	12,503	12,895	11,099	7,731
Gross Profit	13,298	13,359	12,652	9,808	4,874
Selling, General & Admin	4,202	4,171	4,180	3,798	3,296
Operating Expenses	4,202	4,171	4,180	3,798	3,296
Operating Income	9,096	9,188	8,472	6,010	1,578
Interest Expense	-6.63	-8.33	-2.39	-3.55	-119.76
Interest & Investment Income	226.68	279.47	140.95	45.95	68.78
Earnings From Equity Investments	-0.88	-0.43	-0.9	-0.51	-68.87
Currency Exchange Gain (Loss)	-14.2	-22.73	28.06	-3.27	-1.91
Pretax Income	9,301	9,436	8,638	6,049	1,456
Income Tax Expense	1,737	1,604	1,583	1,072	215.85
Earnings From Continuing Operations	7,564	7,832	7,055	4,977	1,240
Minority Interest in Earnings	-51.96	-57.33	-48.68	-38.54	-24.35
Net Income	7,512	7,775	7,006	4,938	1,216
Net Income to Common	7,512	7,775	7,006	4,938	1,216
Net Income Growth	-3.38%	10.96%	41.88%	306.21%	0.96%
Shares Outstanding (Basic)	795	795	795	795	795
Shares Outstanding (Diluted)	867	867	867	867	867
EPS (Basic)	9.45	9.78	8.81	6.21	1.53
EPS (Diluted)	8.66	8.96	8.08	5.69	1.40
EPS Growth	-3.35%	10.89%	42.00%	306.43%	0.72%
Free Cash Flow	6,333	7,455	5,522	5,067	2,753
Free Cash Flow Per Share	7.30	8.59	6.37	5.84	3.17
Dividend Per Share	5.000	5.000	4.500	3.500	3.200
Dividend Growth	-	11.11%	28.57%	9.38%	-
Gross Margin	52.25%	51.66%	49.53%	46.91%	38.66%
Operating Margin	35.74%	35.53%	33.16%	28.75%	12.52%
Profit Margin	29.52%	30.06%	27.43%	23.62%	9.64%
Free Cash Flow Margin	24.88%	28.82%	21.62%	24.23%	21.84%
EBITDA	10,030	10,115	9,405	6,938	2,553
EBITDA Margin	39.41%	39.11%	36.81%	33.18%	20.26%
D&A For EBITDA	933.81	927.23	933.08	927.49	975.86
EBIT	9,096	9,188	8,472	6,010	1,578
EBIT Margin	35.74%	35.53%	33.16%	28.75%	12.52%
Effective Tax Rate	18.68%	17.00%	18.32%	17.72%	14.83%
Revenue as Reported	25,449	25,862	25,575	20,908	12,605
Advertising Expenses	455.51	537.6	494.86	414.75	233.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.